Cargando…

Evaluation of the Antiviral Potential of Halogenated Dihydrorugosaflavonoids and Molecular Modeling with nsP3 Protein of Chikungunya Virus (CHIKV)

[Image: see text] Antiviral therapy is crucial for the circumvention of viral epidemics. The unavailability of a specific antiviral drug against the chikungunya virus (CHIKV) disease has created an alarming situation to identify or develop potent chemical molecules for remedial management of CHIKV....

Descripción completa

Detalles Bibliográficos
Autores principales:	Puranik, Ninad V., Rani, Ruchi, Singh, Vedita Anand, Tomar, Shailly, Puntambekar, Hemalata M., Srivastava, Pratibha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893968/ https://www.ncbi.nlm.nih.gov/pubmed/31815237 http://dx.doi.org/10.1021/acsomega.9b02900

Ejemplares similares

Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis
por: Puranik, Ninad V., et al.
Publicado: (2018)

Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylation
por: Rathore, Abhay P S, et al.
Publicado: (2013)

Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV
por: Singh, Prashant, et al.
Publicado: (2019)

Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
por: Lucero-Obusan, Cynthia A., et al.
Publicado: (2015)

Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity
por: Kumar, Sameer, et al.
Publicado: (2018)

Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus
por: Saha, Amrita, et al.
Publicado: (2018)

Expression and biochemical characterization of nsP2 cysteine protease of Chikungunya virus
por: Pastorino, Boris A.M., et al.
Publicado: (2008)

Analysis of chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity
por: Mathur, Kalika, et al.
Publicado: (2016)

NTPase and 5′-RNA Triphosphatase Activities of Chikungunya Virus nsP2 Protein
por: Karpe, Yogesh A., et al.
Publicado: (2011)

Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus
por: Nguyen, Phuong T. V., et al.
Publicado: (2014)

1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors
por: Ivanova, Larisa, et al.
Publicado: (2021)

Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)
por: Broeckel, Rebecca, et al.
Publicado: (2015)

Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores
por: Jones, Rhian, et al.
Publicado: (2023)

Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
por: Bhakat, Soumendranath, et al.
Publicado: (2015)

Genomic surveillance of the Chikungunya Virus (CHIKV) in Northeast Brazil after the first outbreak in 2014
por: Rodrigues, Ayslany Melo, et al.
Publicado: (2020)

In-silico prediction of novel drug-target complex of nsp3 of CHIKV through molecular dynamic simulation
por: Kumar, Durgesh, et al.
Publicado: (2020)

Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors
por: Agarwal, T., et al.
Publicado: (2015)

Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus
por: Fros, Jelke J., et al.
Publicado: (2015)

The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection
por: Delang, L., et al.
Publicado: (2016)

Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design
por: Zhang, Sixue, et al.
Publicado: (2021)

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate
por: Abeyratne, Eranga, et al.
Publicado: (2018)

Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island
por: Hoarau, Jean-Jacques, et al.
Publicado: (2013)

Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes
por: Göertz, Giel P., et al.
Publicado: (2018)

Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4
por: Martins, Daniel Oliveira Silva, et al.
Publicado: (2022)

A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme
por: Bullard-Feibelman, Kristen M., et al.
Publicado: (2016)

Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication
por: Krieg, Sarah, et al.
Publicado: (2023)

Chikungunya virus (CHIKV) seroprevalence in the South Pacific populations of the Cook Islands and Vanuatu with associated environmental and social factors
por: Saretzki, Charlotte E. B., et al.
Publicado: (2022)

Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness
por: Mounce, Bryan C., et al.
Publicado: (2017)

Targeted in vitro gene silencing of E2 and nsP1 genes of chikungunya virus by biocompatible zeolitic imidazolate framework
por: Tagore, Rajarshee, et al.
Publicado: (2022)

Sindbis Virus nsP2 Endopeptidase
por: Strauss, Ellen G., et al.
Publicado: (2013)

Transcriptome analysis of human macrophages upon chikungunya virus (CHIKV) infection reveals regulation of distinct signaling and metabolic pathways during the early and late stages of infection
por: Srivastava, Priyanshu, et al.
Publicado: (2023)

Expression of Plasmid-Based shRNA against the E1 and nsP1 Genes Effectively Silenced Chikungunya Virus Replication
por: Lam, Shirley, et al.
Publicado: (2012)

Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine
por: Saisawang, Chonticha, et al.
Publicado: (2015)

Cell-Type-Dependent Role for nsP3 Macrodomain ADP-Ribose Binding and Hydrolase Activity during Chikungunya Virus Infection
por: Kim, Taewoo, et al.
Publicado: (2022)

Chikungunya antibodies detected in non-human primates and rats in three Indian Ocean islands after the 2006 ChikV outbreak
por: Vourc’h, Gwenaël, et al.
Publicado: (2014)

Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins
por: Rani, Ruchi, et al.
Publicado: (2022)

Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue
por: Rausalu, Kai, et al.
Publicado: (2016)

Advances in structure-assisted antiviral discovery for animal viral diseases
por: Tomar, Shailly, et al.
Publicado: (2020)

Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV)
por: Jain, Jaspreet, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mtg46r8s0vfsfjfkqkkd745imm